ProCE Banner Activity

Genomic Alterations in Lung and Thyroid Cancer: Guidance on Molecular Testing for Precision Therapy

Slideset Download
Download this slideset on the management of NTRK and RET-altered lung and thyroid cancer with targeted therapies.

Released: November 17, 2022

Expiration: November 16, 2023

Begin Activity

Share

Faculty

Saad A. Khan

Saad A. Khan, MD

Assistant Professor of Medicine (Oncology)
Leader
, Endocrine Cancers Research Group
Stanford Cancer Institute
Stanford University
Stanford, California

Sandip P. Patel

Sandip P. Patel, MD

Professor
Division of Hematology and Medical Oncology
UC San Diego Moores Cancer Center
La Jolla, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Partners

ASCP -Clinical Pathology

ProCE Banner

Faculty Disclosure

Primary Author

Saad A. Khan, MD

Assistant Professor of Medicine (Oncology)
Leader
, Endocrine Cancers Research Group
Stanford Cancer Institute
Stanford University
Stanford, California

Saad A. Khan, MD:consultant/advisor/speaker: Eisai, EMD Serono, Foundation Medicine; Roche Pakistan

Sandip P. Patel, MD

Professor
Division of Hematology and Medical Oncology
UC San Diego Moores Cancer Center
La Jolla, California

Sandip P. Patel, MD:consultant/advisor/speaker: Amgen, AstraZeneca, Bristol-Myers Squibb, Certis, Eli Lilly, Genentech, Illumina , Merck, Pfizer, Rakuten, Tempus; researcher: Amgen, AstraZeneca/MedImmune, Bristol-Myers Squibb, Eli Lilly, Fate Therapeutics, Iovance, Merck, Pfizer, Roche/Genentech, SQZ Biotechnologies.